Investigations Y-mAbs Therapeutics, Inc. Y-mAbs Therapeutics, Inc. (YMAB) Misrepresented the Viability and Efficacy of its Lead Drug Candidate Read More January 20, 2023
Investigations Latch, Inc. Latch, Inc. (LTCH) f/k/a TS Innovation Acquisitions Corp. (TSIA) Issued a False and Misleading Registration Statement in Connection with its Merger Read More January 13, 2023
Investigations Enovix Corporation Enovix Corporation (ENVX) Misled Investors Regarding its Ability for Production and Profitability Read More January 9, 2023
Investigations ForgeRock, Inc. Robbins LLP is Investigating the Acquisition of ForgeRock, Inc. by Thoma Bravo Read More January 6, 2023
Investigations BioLineRx Ltd. BioLineRx Ltd. (BLRX) Misrepresented its Financial Fortitude and Ability to Bring its Drug to Market Read More January 6, 2023
Investigations Avaya Holdings Corp. Avaya Holdings Corp. (AVYA) Failed to Disclose Deficient Internal Control Over Financial Reporting Read More January 5, 2023
Investigations Gaotu Techedu, Inc. f/k/a GSX Techedu, Inc. Gaotu Techedu, Inc. (GOTU) Failed to Disclose the Impact of China’s Ban on For-Profit Tutoring on Its Business Prospects Read More January 3, 2023
Investigations Daktronics, Inc. Daktronics, Inc. (DAKT) Unable to Timely File SEC Reports and Questions its Ability to Continue as a Going Concern Read More December 28, 2022
Investigations Gaia, Inc. Gaia, Inc. (GAIA) Overstated its Subscriber Count and Lacked Adequate Internal Controls Read More December 28, 2022